The Lynx Group

Caroline Helwick


Authored Items

Pathways Creating More and More Value

September 2013, Vol 2, No 6 - Uncategorized

Hollywood, FL – Pathways continue to be refined toward value-based care, adapting to the challenges of a rapidly shifting oncology landscape, as 2 speakers at the Third Annual Conference of the Association for Value-Based Cancer Care described. Michael A. Kolodziej, MD, National Medical Director for Oncology Strategies at Aetna, Hartford, [ Read More ]

Liposomal Vincristine Allows for Greater Dose Density Without Increased Neurotoxicity

April 2013, Vol 2, No 2 - Uncategorized

In August 2012, vincristine sulfate LIPOSOME injection (VSLI; Marqibo) was granted accelerated approval by the FDA for the treatment of adult patients with Philadelphia chromosome–negative acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed after 2 or more antileukemia therapies.1 At the 2012 American Society [ Read More ]

Sign me up!